Dr. Taner Karagöl

Ventures & Translational IP

Independent patent applications, conditional protein and peptide design platforms, and open-science research initiatives.

Patent Applications & Therapeutic Platforms

Published national patent filings supported by competitive PatentleTürkiye grants.

TR Patent Application 2024/018998|Co-Inventor (Karagöl T.*, Karagöl A.*)
PatentleTürkiye Grant

Environment-Responsive Protein & Peptide Design (pI-code)

Filing title: A Method for Designing pH-Specific Proteins with High Topological Similarity Using Serial Consecutive Single Nucleotide Variations

Evolutionarily informed single-base substitution platform for tuning protein isoelectric points and engineering pH-selective activation across acidic tumor, inflammatory, and ischemic microenvironments while preserving native fold topology.

Conditional Protein Design / Oncology & Inflammation / pH-Responsive Therapeutics

TR Patent Application 2024/018993|Co-Inventor (Karagöl T., Karagöl A.)
PatentleTürkiye Grant

STING Truncated-Isoform Immunomodulators

Filing title: Regulation of Immune Activation and Inflammatory Response with a Truncated STING Isoform for the Treatment of Autoimmune Diseases and Inflammation

Biologically inspired truncated STING splice-isoform candidates engineered to modulate receptor oligomerization, cGAS-STING pathway signaling, and systemic inflammatory responses in autoimmune disease.

Innate Immunity / Autoimmune Disease / Isoform-Guided Modulation

TR Patent Application 2024/018735|Co-Inventor (Karagöl T., Karagöl A.)
PatentleTürkiye Grant

VAMP2 Synaptic Modulation & SNARE Inhibition

Filing title: Use of a Truncated Isoform of the VAMP2 Protein in the Treatment of Neurological Diseases and Neuromodulation Applications

Targeted truncated-isoform and peptide disruption of VAMP2 dimerization and SNARE complex assembly for synaptic modulation, neuromuscular blockade, and neurological pain therapeutics.

Neurology / Pain Therapeutics / Synaptic Engineering

Additional Invention Disclosures & Provenance Note

Four additional therapeutic peptide invention disclosures are currently under institutional technology-transfer review. All patent applications, invention disclosures, and the pI-code platform listed on this page represent independent work developed during medical school prior to and separate from my appointment at the Massachusetts Institute of Technology (* co-first inventors).

Initiatives & Translational Milestones

Open-Science InitiativeCo-Founder

Karagöl Research

Collaborative computational biology and protein engineering platform co-founded with Dr. Alper Karagöl, hosting open webservers (ADEPT, GapCheck, pI-code, Evolutionary Statistics Toolkit), Python packages on PyPI, reproducible simulation workflows, and international student research mentorship.

Conditional Binder Design & Innovation2024 - 2026

Competitive Translational Benchmarks

  • Anthropic x Adaptyv Protein Design Challenge (2026): Publicly deposited conditional miniprotein binder designs applying pI-code charge filtering to histidine-switched EGFR recognition.
  • PatentleTürkiye National Patent Grants (2024 - 2025): Three competitive national awards supporting independent filings in pH-specific protein design and truncated-isoform therapeutics.
  • TEKNOFEST Biotechnology Innovation Competition (2026): National finalist across two separate translational biotechnology teams.